These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3907826)

  • 21. Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
    Shildt R; Stephens RL; Subramanian VP; Baker LH; Fletcher WS; O'Bryan RM; McCracken JD
    Cancer Treat Rep; 1985 Jun; 69(6):709-10. PubMed ID: 4016775
    [No Abstract]   [Full Text] [Related]  

  • 22. Carboplatin in advanced, refractory germ cell neoplasms: a phase II Eastern Cooperative Oncology Group Study.
    Trump DL; Elson P; Brodovsky H; Vogl SE
    Cancer Treat Rep; 1987 Oct; 71(10):989-90. PubMed ID: 2820572
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
    Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
    Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of iproplatin in advanced or metastatic stomach cancer. The EORTC Early Clinical Trial Group.
    Sessa C; Cerny T; Kaye S; Monfardini S; Rénard J; Cavalli F
    Eur J Cancer; 1990 Jan; 26(1):61-2. PubMed ID: 2138481
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxaliplatin-induced immune mediated thrombocytopenia.
    Beg MS; Komrokji RS; Ahmed K; Safa MM
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Aug; 13(8):1116-8. PubMed ID: 10499245
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 29. Carboplatin (JM-8, CBDCA). A new platinum compound.
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):1-48. PubMed ID: 2655092
    [No Abstract]   [Full Text] [Related]  

  • 30. Whither carboplatin? A replacement for or an alternative to cisplatin?
    Gil A
    J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxaliplatin: new opportunities for the treatment of gastrointestinal cancer.
    MacDonald JS
    Cancer Invest; 2002; 20(2):287-9. PubMed ID: 11901548
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
    Budman DR; Ginsberg S; Perry M; Weinberg V; Schein P; Hanson J; Coleman M; Wood W
    Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial.
    Omura GA; Bartolucci AA; Lessner HE; Hill GJ
    Cancer Treat Rep; 1984 Jun; 68(6):929-30. PubMed ID: 6547369
    [No Abstract]   [Full Text] [Related]  

  • 36. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges in advanced NSCLC: optimizing platinum-based chemotherapy and treating special populations.
    Belani CP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S10-22. PubMed ID: 19780242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraplatin (carboplatin): new advances in cancer therapy. Update on clinical experiences. Proceedings of a satellite symposium. Madrid, Spain, 2 November 1987.
    Cancer Treat Rev; 1988 Jun; 15 Suppl B():1-44. PubMed ID: 3042129
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA) in humans].
    Zucca E; Cattaneo MT; Cavalli F; Guaitani A; Filipazzi V; Bartosek I
    G Ital Chemioter; 1985; 32(1):25-8. PubMed ID: 3913618
    [No Abstract]   [Full Text] [Related]  

  • 40. A phase Ib and pharmacokinetic trial of patupilone combined with carboplatin in patients with advanced cancer.
    Forster M; Kaye S; Oza A; Sklenar I; Johri A; Cheung W; Zaknoen S; Gore M
    Clin Cancer Res; 2007 Jul; 13(14):4178-84. PubMed ID: 17634546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.